Tag: Prescription Drugs
Study Compares Hospitalized Infection Risk for Biologics in RA
Risk of hospitalized infection increased with etanercept, infliximab, rituximab versus abatacept
Benznidazole Tx Explored in Chagas’ Cardiomyopathy
Reduces serum parasite detection but does not reduce cardiac clinical deterioration through 5 years
Bivalirudin Doesn’t Lower Major Cardiovascular Event Rate in ACS
No decrease in rate of major CV events, net adverse clinical events for patients undergoing PCI
Osteonecrosis of Jaw Risk Highest for IV Bisphosphonate Use
High risk for zoledronate, denosumab mainly in prevention of skeletal-related events
Intravenous Cyclosporine Doesn’t Improve STEMI Outcomes
For patients undergoing PCI, cyclosporine doesn't prevent adverse left ventricular remodeling at 1 year
Lower Risk of Dabigatran-Tied Bleeding With Gastroprotection
Concomitant use of gastroprotective agents linked to lower risk of gastrointestinal bleeding
Patient Satisfaction Up for Dulaglutide Treatment in T2DM
Improvement in patient satisfaction, decrease in perceived frequency of hyperglycemia
Daratumumab Monotherapy Promising for Multiple Myeloma
Findings in a phase 1-2 study of patients with relapsed myeloma or relapsed/refractory myeloma
Periop Bridging Unnecessary for Most A-Fib Patients on Warfarin
Arterial thromboembolism risk doesn't appear to rise without additional drug treatment
FDA Issues Proposal on Lower-Cost, Generic Biotech Drugs
All biotech drugs to carry a four-letter code to distinguish brand name, generic versions
